Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5937616 | The American Journal of Pathology | 2009 | 9 Pages |
Abstract
Sphingosine kinase (SK)-1 promotes endothelial cell (EC) survival through the cell junction molecule CD31 (platelet endothelial cell adhesion molecule-1). The integrin αvβ3 is also essential for EC survival; inhibition of αvβ3 ligation promotes apoptosis. Herein we demonstrate that under basal conditions, SK-1, αvβ3, and CD31 exist as a heterotrimeric complex. Under conditions that affect EC survival such as loss of contact with the extracellular matrix or growth factor activation, more of this heterotrimeric complex forms. Overexpression studies demonstrate a requirement for SK-1 phosphorylation at serine 225 for increased heterotrimeric complex formation, activation of αvβ3, and EC survival signals, including Bcl-X and nuclear factor-κB pathways. Moreover, β3 integrin depletion confirmed the requirement for this heterotrimeric complex in SK-1-mediated EC survival. Thus, with αvβ3 integrin being identifiable primarily on angiogenic ECs and SK-1 being highly expressed in tumors, targeting SK-1 may affect multiple survival pathways, and its inhibition may be highly efficacious in controlling pathological EC survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jennifer R. Gamble, Wai Y. Sun, Xiaochun Li, Christopher N. Hahn, Stuart M. Pitson, Mathew A. Vadas, Claudine S. Bonder,